Opportunities Preloader

Please Wait.....

Report

South & Central America Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)

Market Report I 2022-10-07 I 113 Pages I The Insight Partners

The influenza vaccines market in South & Central America is expected to grow from US$ 497.54 million in 2022 to US$ 736.35 million by 2028. It is estimated to grow at a CAGR of 6.8% from 2022 to 2028.

Emerging Economies

Leading players in the influenza vaccines market focus on expanding their customer reach across emerging markets by expanding their distribution networks and augmenting their manufacturing capabilities. In addition, high investments in life science and healthcare research in emerging countries play a crucial role in upgrading the latest technologies in developing countries. In turn, this supports the inclination toward advanced vaccine development. Key producers of influenza vaccines in Brazil is expected to witness lucrative opportunities in the near future due to the large patient pool and high prevalence of influenza, improving healthcare infrastructure, rising disposable income, and the surge of medical tourism in these countries.

Market Overview

South & Central America influenza vaccines market includes Brazil, Argentina, and Rest of South and Central America. The region held smallest portion of the market in the global analysis. The market for influenza vaccines in the region is expected to have growth opportunities during the forecast period. The influenza vaccines market in the South & Central America region is expected to grow owing to factors such as, an increase in cases of influenza in the region, surge in various research activities in the region, increasing awareness, and rising healthcare expenditure by the countries of the region. Brazil has made huge strides in healthcare sector owing to increasing healthcare expenditure. As per the International Trade Administration (ITA), Brazil is the largest healthcare market in Latin America and spends 9.1% of its GDP in healthcare in 2020. The influenza vaccines market in Brazil is expected to flourish owing to factors such as, surge in vaccination programs in the country, and rising healthcare expenditure by the country. In Brazil, influenza epidemics significantly weigh on the Brazilian healthcare system and society, with an estimated number of ILI cases as high as 83 million in a year. Brazil has one of the most extensive immunization programs worldwide. Since 1999, the influenza vaccines has been provided free of charge to older adults (aged 60 years or more) in the whole count. Public health authorities have then progressively expanded the recommendation to the pediatric age groups by first including, in 2011, children aged from 6 months to under 2yo, then under 5yo in 2016, and in 2019 to all children from 6 months to 6 years of age. Vaccination campaigns are nationwide. These campaigns occur every year for two weeks, before the colder season, in all primary healthcare units. The trivalent and inactivated influenza vaccines is produced by a national laboratory (Instituto Butantan) and administered in private health establishments. As per the Journal of Infection and Public Health, Vaccination coverage remained close to the target of 75% proposed by the World Health Organization. The most relevant factors influencing vaccination have been health-related measures; lifestyle and socioeconomic status also played an essential role in predicting vaccines uptake

South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Influenza Vaccines Market Segmentation

The South & Central America Influenza Vaccines Market is segmented into vaccine type, virus type, technology, route of administration, and country.

Based on vaccine type, the South & Central America influenza vaccines market is divided into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered the larger market share in 2022.

Based on virus type, the South & Central America influenza vaccines market is segmented into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger market share in 2022.

Based on technology, the South & Central America influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger market share in 2022.

Based on route of administration, the South & Central America influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger market share in 2022.

Based on country, the market is segmented into Brazil, Argentina, and the rest of South & Central America. Brazil dominated the market share in 2022.

AstraZeneca; GlaxoSmithKline plc.; Hualan Biological Engineering Inc.; Mitsubishi Chemical Group Corporation; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the influenza vaccines market in South & Central America.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Influenza Vaccines Market - By Vaccine Type
1.3.2 South & Central America Influenza Vaccines Market - By Virus Type
1.3.3 South & Central America Influenza Vaccines Market - By Technology
1.3.4 South & Central America Influenza Vaccines Market - By Route Of Administration
1.3.5 South & Central America Influenza Vaccines Market - By Country
2. Influenza Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Influenza Vaccines Market Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 Experts Opinion
5. South & Central America Influenza Vaccines Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Government Support to Promote Influenza Vaccination
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market - South & Central America Analysis
6.1 South & Central America Influenza Vaccines Market Revenue Forecasts And Analysis
7. South & Central America Influenza Vaccines Market- By Vaccine Type
7.1 Overview
7.2 South & Central America Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. South & Central America Influenza Vaccines Market- By Virus Type
8.1 Overview
8.2 South & Central America Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9. South & Central America Influenza Vaccines Market By Technology
9.1 Overview
9.2 South & Central America Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.3 Egg-Based
9.3.1 Overview
9.3.2 South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-Based
9.4.1 Overview
9.4.2 South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. South & Central America Influenza Vaccines Market- By Route of Administration
10.1 Overview
10.2 South & Central America Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.3 Injection
10.3.1 Overview
10.3.2 South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. South & Central America Influenza Vaccines Market Country Analysis
11.1 South & Central America Influenza Vaccine Market Revenue and Forecasts to 2028
11.1.1 Overview
11.1.3 South & Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
11.1.3.1 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.3.1.1 Overview
11.1.3.1.2 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.3.1.3 Brazil: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
11.1.3.1.4 Brazil: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
11.1.3.1.5 Brazil: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
11.1.3.1.6 Brazil: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
11.1.3.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.3.2.1 Overview
11.1.3.2.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.3.2.3 Argentina: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
11.1.3.2.4 Argentina: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
11.1.3.2.5 Argentina: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
11.1.3.2.6 Argentina: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
11.1.3.3 Rest of South & Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.3.3.1 Overview
11.1.3.3.2 Rest of South & Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.3.3.3 Rest of South & Central America: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
11.1.3.3.4 Rest of South & Central America: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
11.1.3.3.5 Rest of South & Central America: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
11.1.3.3.6 Rest of South & Central America: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
12. South & Central America Influenza Vaccine Market -Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 SEQIRUS
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Hualan Biological Engineering Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Mitsubishi Chemical Group Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Serum Institute of India Pvt. Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MYLAN N.V.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AstraZeneca
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES


Table 1. South & Central America Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 5. Brazil: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South & Central America: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of South & Central America: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of South & Central America: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of South & Central America: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 14. Recent Inorganic Growth Strategies in the South & Central America Influenza Vaccine Market
Table 15. Recent Organic Growth Strategies in the South & Central America Influenza Vaccine Market
Table 16. Glossary of Terms, South & Central America Influenza Vaccines Market



LIST OF FIGURES


Figure 1. South & Central America Influenza Vaccines Market Segmentation
Figure 2. South & Central America Influenza Vaccines Market Segmentation, by Country
Figure 3. South & Central America Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in South & Central America Influenza Vaccines Market
Figure 5. Brazil Is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. South & Central America: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Impact Analysis
Figure 10. South & Central America Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
Figure 11. South & Central America Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 12. South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. South & Central America Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 15. South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. South & Central America Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 18. South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. South & Central America Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 21. South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. South & Central America: Influenza Vaccine Market, by Key Country - Revenue (2022) (USD Million)
Figure 24. South & Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
Figure 25. Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 26. Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 27. Rest of South & Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE